Court of Justice of the European Union press release: The Commission did not give the public sufficiently wide access to the purchase agreements for Covid-19 vaccines curia.europa.eu/jcms/upload/do…

ABBVIE TO FACE HUMAN RIGHTS SUIT OVER DRUG PRICES: A Dutch court will hear a health NGO’s lawsuit accusing pharma company AbbVie of violating human rights with excessive prices for rheumatoid arthritis drug Humira. pro.politico.eu/news/d-day-for… Pharmaceutical Accountability Foundation

New HIV drug can only offer hope of ending AIDS if all have access, UNAIDS says (And Gilead Sciences can make that happen) unaids.org/en/resources/p…

A pricey Gilead HIV drug could be made for dramatically less than the company charges, researchers say statnews.com/pharmalot/2024… via STAT

Good The Lancet piece on the Pharmaceutical Accountability Foundation’s Stichting Farma ter Verantwoording legal case against AbbVie for its excessive pricing of Humira thelancet.com/action/showPdf…

Drugmaker Sinergium to share bird flu vaccine data globally, says WHO reuters.com/business/healt…

Pfizer's , GSK's and Moderna's competition for arms for their new respiratory syncytial virus (RSV) vaccines is on Wall Street's watch list for when the companies report earnings later this week. reut.rs/3YnRMq7 reut.rs/3YnRMq7

Pharma funded patient group removes critical comments upon funder’s demand. statnews.com/2024/07/29/sar…

On current settings, people most at risk in low-income countries won’t get fast access to vaccines against #Mpox. The inequitable system experienced during #Covid_19 #pandemic has not changed. No #pandemic agreement covering these issues has been negotiated. WTO won’t move either

Reviewing TRIPS, an opportunity for evidence-based policies, writes KM Gopakumar of Third World Network (and overdue) thehindubusinessline.com/specials/pulse…

Our big story this week: A potentially landmark court case on a cystic fibrosis treatment has been dropped following a price cut. The court was being asked to grant a compulsory license spotlightnsp.co.za/2024/08/06/cas… @tac James Packard Love MSF Access Campaign Ellen 't Hoen SECTION27 Balasubramaniam

Amsterdam UMC: Ronald Plasterk claimde ten onrechte alleenrecht patenten - nrc.nl/nieuws/2024/08… nrc.nl/nieuws/2024/08…

Monday, September 2nd, 2024 at 2 PM CEST: Reflections on the IP/Technology transfer provisions of the World Health Organization (WHO) Pandemic Agreement featuring James Packard Love Ellen 't Hoen and Luis Villarroel #INB11 h/t Arianna Schouten

. World Health Organization (WHO) urges rapid access to #mpox diagnostic tests, invites manufacturers to emergency review who.int/news/item/29-0…

We scored a big win when J&J dropped their patent on #TB medicine after the CompComSA initiated a probe. 20 years ago, a similar case helped drive down #antiretroviral prices, write Fatima Hassan @[email protected] and Leena Menghaney. Health Justice Initiative - HJI MSF International Health Justice Initiative - HJI spotlightnsp.co.za/2024/08/30/com…

An HIV prevention drug that is 100% effective: this is a game-changer! Now to ensure lives over profit. Pleased to see The Lancet back UNAIDS Global' call for Gilead Sciences to make lenacapavir available rapidly & affordably to all who need in low- & middle-income countries.

Finally. lemonde.fr/sante/article/…

At McGill School of Population and Global Health McGill Global Health Programs McGill Medicine and Health Sciences McGill University, we are truly delighted to announce Mr. Zackie Achmat (Zackie Achmat) as the winner of the inaugural Paul Farmer Award for Global Health Equity! Read about Zackie's inspiring work to improve health equity: mcgill.ca/spgh/about-us/…

Pharma is still struggling to widen access to medicines and reach patients, in LMICs. With some pointed quotes from Access to Medicine Foundation director Jayasree Iyer about the "big gap between what the companies say and what they do". statnews.com/pharmalot/2024… via STAT

In a new guest blog by Kieran Harkin, Susan Smith & James Larkin, we learn how members of the Irish College of General Practitioners made the momentous decision to stop accepting funding from the pharma industry. 📖Read the blog to find out more: haiweb.org/how-a-gp-group…